{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:56:08Z","timestamp":1791395768028,"version":"4.3.3"},"reference-count":16,"publisher":"BMJ","funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2025-25423084"],"award-info":[{"award-number":["RS-2025-25423084"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,9,21]]},"DOI":"10.1136\/thorax-2026-225820","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:20:31Z","timestamp":1791393631000},"page":"thorax-2026-225820","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["To test or not to test: reassessing the need for drug response assessment before inhaled hypertonic saline"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-0653","authenticated-orcid":false,"given":"Hayoung","family":"Choi","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026100710202627000_thorax-2026-225820v1.1","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/all.13435","article-title":"Incidence of cephalosporin-induced anaphylaxis and clinical efficacy of screening intradermal tests with cephalosporins: A large multicenter retrospective cohort study","volume":"73","author":"Yang","year":"2018","journal-title":"Allergy"},{"key":"2026100710202627000_thorax-2026-225820v1.2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/all.12182","article-title":"Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge","volume":"68","author":"Yoon","year":"2013","journal-title":"Allergy"},{"key":"2026100710202627000_thorax-2026-225820v1.3","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2008.110726","article-title":"Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient","volume":"64 Suppl 1","author":"Bott","year":"2009","journal-title":"Thorax"},{"key":"2026100710202627000_thorax-2026-225820v1.4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01126-2025","article-title":"European Respiratory Society clinical practice guideline for the management of adult bronchiectasis","volume":"66","author":"Chalmers","year":"2025","journal-title":"Eur Respir J"},{"key":"2026100710202627000_thorax-2026-225820v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2026100710202627000_thorax-2026-225820v1.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"2026100710202627000_thorax-2026-225820v1.7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00518-2024","article-title":"Bronchiectasis management in adults: state of the art and future directions","volume":"63","author":"Choi","year":"2024","journal-title":"Eur Respir J"},{"key":"2026100710202627000_thorax-2026-225820v1.8","doi-asserted-by":"crossref","unstructured":"McLeese RH , O\u2019Neill B , McAuley DF , et al . Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial. Thorax 2026.:thorax-2025-224572. doi:10.1136\/thorax-2025-224572","DOI":"10.1136\/thorax-2025-224572"},{"key":"2026100710202627000_thorax-2026-225820v1.9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa2510095","article-title":"Hypertonic Saline or Carbocisteine in Bronchiectasis","volume":"393","author":"Bradley","year":"2025","journal-title":"N Engl J Med"},{"key":"2026100710202627000_thorax-2026-225820v1.10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"2026100710202627000_thorax-2026-225820v1.11","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618787385","article-title":"Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients","volume":"12","author":"M\u00e1iz","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"2026100710202627000_thorax-2026-225820v1.12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026100710202627000_thorax-2026-225820v1.13","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2026100710202627000_thorax-2026-225820v1.14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/resp.14059","article-title":"Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries","volume":"26","author":"Lee","year":"2021","journal-title":"Respirology"},{"key":"2026100710202627000_thorax-2026-225820v1.15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2213-2600(24)00364-3","article-title":"Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study","volume":"13","author":"Xu","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026100710202627000_thorax-2026-225820v1.16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis","volume":"166","author":"Cordeiro","year":"2024","journal-title":"Chest"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:20:36Z","timestamp":1791393636000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":16,"alternative-id":["10.1136\/thorax-2026-225820"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225820","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}